This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Valorisation-Recherche, Societe En Commandite. Active years: 2008-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2014
Title: Francis Girard: Innovator in Antibody Research
Introduction
Francis Girard is a notable inventor based in Saint-Hyacinthe, Canada. He has made significant contributions to the field of immunology, particularly in the development of antibodies that target virulence-associated proteins.
Latest Patents
Girard holds 3 patents related to antibodies that are immunologically specific for attaching and effacing (AEEC) virulence-associated proteins. His inventions focus on products, compositions, and methods aimed at preventing AEEC infections in mammals. The antibodies he developed are capable of preventing in vivo AEEC intestinal infections when administered to mammals. They are particularly useful in preventing the development of A/E intestinal lesions associated with AEEC, utilizing IgY antibodies that target various AEEC virulence-associated proteins, including Eae, Tir, EspA, and Paa.
Career Highlights
Francis Girard is associated with Valorisation-Recherche, Société En Commandite, where he continues to advance his research and innovations in the field of immunology. His work has the potential to significantly impact the prevention of intestinal infections in mammals.
Collaborations
Girard has collaborated with notable colleagues, including John Morris Fairbrother and Josée Harel, contributing to a dynamic research environment that fosters innovation.
Conclusion
Francis Girard's work in antibody research exemplifies the importance of innovation in the field of immunology. His contributions are paving the way for advancements in the prevention of AEEC infections, showcasing the vital role of inventors in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile